Trial · NCT06359665
Registered outcomes33
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 33
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in Pain on the Visual Analog Pain (VAS) Score | Baseline and Week 4, Week 6 | The Visual Analog Pain (VAS) Score is a validated, self-reported subjective measure for measuring acute and chronic pain. Possible scores range from 0 (no pain) to 10 (worst possible pain). Change = (Week (4 or 6) Score - Baseline Score).a validated, self-report |
| Primary | Change from Baseline in Pain on the Visual Analog Pain (VAS) Score - crossover condition | Baseline and Week 10, Week 12 | The Visual Analog Pain (VAS) Score is a validated, self-reported subjective measure for measuring acute and chronic pain. Possible scores range from 0 (no pain) to 10 (worst possible pain). Change = (Week Change = (Week (10 or 12) Score - Baseline Score). |
| Secondary | Change from Baseline in Normal Function on the Single Assessment Numerical Evaluation (SANE) Score | Baseline and Week 4, Week 6 | The SANE Score is a self-reported subjective measure for measuring percentage of normal function. Possible scores range from 0 (most abnormal) to 100 (normal). Change = (Week (4 or 6) Score - Baseline Score) |
| Secondary | Change from Baseline in Normal Function on the Single Assessment Numerical Evaluation (SANE) Score - crossover condition | Baseline and Week 10, Week 12 | The SANE Score is a self-reported subjective measure for measuring percentage of normal function. Possible scores range from 0 (most abnormal) to 100 (normal). Change = (Week 10, Week 12 Score - Baseline Score) |
| Secondary | Change from Baseline in Quality of Life on the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-10 Score | Baseline and Week 4, Week 6 | The PROMIS Global Health-10 is a validated, self-reported subjective measure for measuring generic health related quality of life. Possible scores range from 0 (most severe impairment) to 20 (best health). Change = (Week (4 or 6) Score - Baseline Score) |
| Secondary | Change from Baseline in Quality of Life on the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-10 Score - crossover condition | Baseline and Week 10, Week 12 | The PROMIS Global Health-10 is a validated, self-reported subjective measure for measuring generic health related quality of life. Possible scores range from 0 (most severe impairment) to 20 (best health). Change = (Week (10 or 12) Score - Baseline Score) |
| Secondary | Change from Baseline in Pain interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score | Baseline and Week 4, Week 6 | The PROMIS Pain Interference is a validated, self-reported subjective measure for measuring generic health related quality of life. Possible scores range from 0 (does not interfere) to 10 (completely interferes). Change = (Week (4, 6) Score - Baseline Score) |
| Secondary | Change from Baseline in Pain interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score - crossover condition | Baseline and Week 10, Week 12 | The PROMIS Pain Interference is a validated, self-reported subjective measure for measuring generic health related quality of life. Possible scores range from 0 (does not interfere) to 10 (completely interferes). Change = (Week (10, 12) Score - Baseline Score) |
| Secondary | Change from Baseline in Pain interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity (UE) Score | Baseline and Week 4, Week 6 | The PROMIS UE computer adaptive test is a validated computer adaptive test to assess upper extremity functional status. Change = (Week (4, 6) Score - Baseline Score) |
| Secondary | Change from Baseline in Pain interference on the Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity (UE) Score | Baseline and Week 10, Week 12 | The PROMIS UE computer adaptive test is a validated computer adaptive test to assess upper extremity functional status. Change = (Week (10, 12) Score - Baseline Score) |
| Secondary | Change from Baseline in Pain on the Australian/Canadian Hand Osteoarthritis (AUSCAN) Index | Baseline and Week 4, Week 6 | The AUSCAN Index is a 15-item scale measuring pain (5 items), stiffness (1 item) and function (9 items) during the preceding 48 hours. Possible scores range from 0 (none) to 4 (extreme). Change = (Week (4, 6) Score - Baseline Score) |
| Secondary | Change from Baseline in Pain on the Australian/Canadian Hand Osteoarthritis (AUSCAN) Index | Baseline and Week 10, Week 12 | The AUSCAN Index is a 15-item scale measuring pain (5 items), stiffness (1 item) and function (9 items) during the preceding 48 hours. Possible scores range from 0 (none) to 4 (extreme). Change = (Week (10, 12) Score - Baseline Score) |
| Secondary | Change from Baseline in Disability on The Quick Disability of the Arm, Shoulder (QuickDASH). | Baseline and Week 4 | The QuickDASH is a validated, self-reported 11-item scale measuring disability. Possible scores range from 0 (no disability) to 100 (most severe disability. Change = (Week 4 Score - Baseline Score) |
| Secondary | Change from Baseline in Disability on The Quick Disability of the Arm, Shoulder (QuickDASH) - crossover condition | Baseline and Week 10 | The QuickDASH is a validated, self-reported 11-item scale measuring disability. Possible scores range from 0 (no disability) to 100 (most severe disability. Change = (Week 10 Score - Baseline Score) |
| Secondary | Change from Baseline in perseverance on the Brief Resilience Index (BRI) | Baseline and Week 4, Week 6 | The BRI is a validated, self-reported 6-item validated tool to assess for resilience. Possible scores range from 1 (low resilience) to 5 (high resilience). Change = (Week (4, 6) Score - Baseline Score) |
| Secondary | Change from Baseline in perseverance on the Brief Resilience Index (BRI) - crossover condition | Baseline and Week 10, Week 12 | The BRI is a validated, self-reported 6-item validated tool to assess for resilience. Possible scores range from 1 (low resilience) to 5 (high resilience). Change = (Week (10, 12) Score - Baseline Score) |
| Secondary | Number of Participants With Treatment-Related Adverse Events | Through study completion, an average of 12 weeks | Treatment-related adverse events will be reported throughout the study by self-report and clinician-driven questions at each visit |
| Secondary | Change from Baseline in the Mean Seated Trough Cuff Systolic Blood Pressure | Baseline and Week 4 | Blood pressure (SBP and DBP) in mmHg using Sphygmomanometer will be assessed by the researchers at baseline and follow-up |
| Secondary | Change from Baseline in heart rate | Baseline and Week 4 | Heartbeats per minute (BPM) will be assessed by the researchers at baseline and follow-up |
| Secondary | Change from Baseline in the Mean Seated Trough Cuff Systolic Blood Pressure | Week 4 and Week 6 | Blood pressure (SBP and DBP) in mmHg using Sphygmomanometer will be assessed by the researchers at baseline and follow-up |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06359665/registered